Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 29, 2021

Primary Completion Date

August 11, 2022

Study Completion Date

August 11, 2022

Conditions
Diabetes Mellitus
Interventions
DEVICE

The Omnipod 5/Horizon HCL system

"The Omnipod 5/Horizon HCL system, consists of a disposable insulin infusion pump (or pod), a built-in model predictive control (MPC) insulin dosing algorithm, and a remote Personal Diabetes Manager (PDM) interface, that interact with a Dexcom G6 continuous glucose monitor (CGM) to automatically control insulin delivery based upon real-time glucose values. The PDM component also enables remote interaction with the system, including glucose monitoring as well as insulin dosing management and adjustments."

Trial Locations (3)

22903

University of Virginia School of Medicine, Charlottesville

30322

Grady Health System (non-CRN), Atlanta

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

Insulet Corporation

INDUSTRY

collaborator

Jaeb Center for Health Research

OTHER

lead

Emory University

OTHER